139 related articles for article (PubMed ID: 33410472)
1. Increased proportion of comorbidities but no deterioration of sexual quality of life during a 5-year follow-up in patients with axial spondyloarthritis in the biologic treatment era.
Berg KH; Rohde G; Pripp A; Prøven A; Pirelli Benestad EE; Østensen M; Haugeberg G
Rheumatology (Oxford); 2021 Sep; 60(9):4112-4120. PubMed ID: 33410472
[TBL] [Abstract][Full Text] [Related]
2. Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era.
Berg KH; Rohde GE; Prøven A; Benestad EEP; Østensen M; Haugeberg G
J Rheumatol; 2019 Sep; 46(9):1075-1083. PubMed ID: 30770521
[TBL] [Abstract][Full Text] [Related]
3. Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States.
Zhao SS; Ermann J; Xu C; Lyu H; Tedeschi SK; Liao KP; Yoshida K; Moots RJ; Goodson NJ; Solomon DH
Rheumatology (Oxford); 2019 Nov; 58(11):2025-2030. PubMed ID: 31081033
[TBL] [Abstract][Full Text] [Related]
4. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
5. The relationship between demographic- and disease-related variables and health-related quality of life in patients with axial spondyloarthritis.
Rohde G; Berg KH; Prøven A; Haugeberg G
BMC Musculoskelet Disord; 2017 Aug; 18(1):328. PubMed ID: 28764693
[TBL] [Abstract][Full Text] [Related]
6. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
7. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
8. Validation and cultural adaptation of the qualisex questionnaire in patients with axial spondyloarthritis in Argentina.
Sommerfleck FA; Schneeberger EE; Orozco MC; Zamora N; Landi M; Citera G
Rheumatol Int; 2018 Nov; 38(11):2103-2109. PubMed ID: 30167765
[TBL] [Abstract][Full Text] [Related]
9. Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides).
Moreno M; Gratacós J; Navarro-Compán V; de Miguel E; Font P; Clavaguera T; Linares LF; Joven B; Juanola X;
Clin Exp Rheumatol; 2018; 36(6):1038-1042. PubMed ID: 29745878
[TBL] [Abstract][Full Text] [Related]
10. Are extra-spinal symptoms associated with quality of life in patients with axial spondyloarthritis? A 1-year follow-up study.
Kwan YH; Fong W; Leung YY; Lui NL; Tan CS; Malhotra R; Østbye T; Thumboo J
Clin Rheumatol; 2019 Jul; 38(7):1881-1887. PubMed ID: 30903309
[TBL] [Abstract][Full Text] [Related]
11. Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data.
D'Angelo S; Gilio M; D'Attino RM; Gualberti G; Merolla R; di Luzio Paparatti U; Malavolta N; Corvaglia S; Marchetta A; Scambi C; Romeo N; Pettiti G; Salvarani C; Catanoso MG; Scarpa R; Costa L; Ramonda R; Frallonardo P; Muratore M; Quarta L; Passiu G; Erre GL; Lubrano D; Tirri E; Govoni M; Furini F; Russo R; Buono R; Pozzi MR; Riva M; Grembiale RD; Bruno C; Gibertini P; Marchesoni A
Clin Exp Rheumatol; 2019; 37(5):748-755. PubMed ID: 30943145
[TBL] [Abstract][Full Text] [Related]
12. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS.
Zhao SS; Jones GT; Macfarlane GJ; Hughes DM; Moots RJ; Goodson NJ
Rheumatology (Oxford); 2021 Sep; 60(9):4158-4165. PubMed ID: 33369676
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.
Luchetti MM; Benfaremo D; Ciccia F; Bolognini L; Ciferri M; Farinelli A; Rossini M; Mosca P; Triolo G; Gabrielli A
World J Gastroenterol; 2017 Oct; 23(39):7139-7149. PubMed ID: 29093622
[TBL] [Abstract][Full Text] [Related]
15. No deterioration in health-related quality of life in patients with axial spondyloarthritis followed for 5 years in ordinary outpatient clinics in the biological treatment era.
Rohde G; Berg KH; Pripp AH; Prøven A; Haugeberg G
Qual Life Res; 2020 Jan; 29(1):99-107. PubMed ID: 31559519
[TBL] [Abstract][Full Text] [Related]
16. Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.
Roseira J; Magro F; Fernandes S; Simões C; Portela F; Vieira AI; Patita M; Leal C; Lago P; Caldeira P; Gago T; Currais P; Dias CC; Santiago M; Dias S; Tavares de Sousa H
Inflamm Bowel Dis; 2020 Apr; 26(5):746-755. PubMed ID: 31504518
[TBL] [Abstract][Full Text] [Related]
17. Burden of illness associated with non-radiographic axial spondyloarthritis: a multiperspective European cross-sectional observational study.
Sieper J; Holbrook T; Black CM; Wood R; Hu X; Kachroo S
Clin Exp Rheumatol; 2016; 34(6):975-983. PubMed ID: 27749215
[TBL] [Abstract][Full Text] [Related]
18. Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action.
Rodrigues-Manica S; Silva J; Cruz-Machado R; Coelho C; Duarte J; Vieira-Sousa E; Tavares-Costa J; Pimentel-Santos FM
Clin Rheumatol; 2021 Jan; 40(1):33-41. PubMed ID: 32533340
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
20. Presence of Fibromyalgia Syndrome and Its Relationship with Clinical Parameters in Patients with Axial Spondyloarthritis.
Rencber N; Saglam G; Huner B; Kuru O
Pain Physician; 2019 Nov; 22(6):E579-E585. PubMed ID: 31775411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
